Concepts (125)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Atrial Fibrillation | 8 | 2025 | 711 | 1.130 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 3 | 2022 | 239 | 0.810 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 2 | 2023 | 139 | 0.740 |
Why?
|
| Histone Deacetylase 2 | 2 | 2023 | 15 | 0.720 |
Why?
|
| Heart Diseases | 2 | 2023 | 490 | 0.680 |
Why?
|
| Myocytes, Cardiac | 8 | 2024 | 609 | 0.660 |
Why?
|
| Prostatic Neoplasms | 5 | 2023 | 1396 | 0.650 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2021 | 169 | 0.640 |
Why?
|
| Heart Atria | 5 | 2025 | 325 | 0.630 |
Why?
|
| Neovascularization, Pathologic | 2 | 2018 | 233 | 0.590 |
Why?
|
| Spectrin | 1 | 2018 | 70 | 0.560 |
Why?
|
| Cardiomyopathies | 1 | 2021 | 494 | 0.510 |
Why?
|
| Thrombospondin 1 | 1 | 2016 | 21 | 0.510 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2016 | 78 | 0.500 |
Why?
|
| Calpain | 2 | 2024 | 41 | 0.380 |
Why?
|
| Arrhythmias, Cardiac | 3 | 2025 | 476 | 0.340 |
Why?
|
| Calcium Signaling | 3 | 2022 | 240 | 0.340 |
Why?
|
| G-Protein-Coupled Receptor Kinase 3 | 2 | 2023 | 9 | 0.330 |
Why?
|
| Signal Transduction | 5 | 2023 | 4472 | 0.330 |
Why?
|
| Gene Knockdown Techniques | 2 | 2021 | 372 | 0.300 |
Why?
|
| Disease Models, Animal | 8 | 2025 | 4426 | 0.290 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 3 | 2018 | 95 | 0.280 |
Why?
|
| Mice | 15 | 2025 | 17594 | 0.280 |
Why?
|
| Fibrosis | 3 | 2025 | 400 | 0.280 |
Why?
|
| Sarcoplasmic Reticulum | 3 | 2022 | 146 | 0.250 |
Why?
|
| Receptors, Cell Surface | 2 | 2025 | 422 | 0.250 |
Why?
|
| Membrane Proteins | 3 | 2024 | 1569 | 0.240 |
Why?
|
| Animals | 18 | 2025 | 33045 | 0.240 |
Why?
|
| Myocardium | 2 | 2020 | 847 | 0.240 |
Why?
|
| Proteomics | 3 | 2025 | 562 | 0.230 |
Why?
|
| Androgen Antagonists | 3 | 2023 | 107 | 0.220 |
Why?
|
| Cyclic AMP Response Element Modulator | 1 | 2024 | 23 | 0.210 |
Why?
|
| Fibroblasts | 2 | 2025 | 819 | 0.210 |
Why?
|
| Muscle Proteins | 3 | 2024 | 398 | 0.210 |
Why?
|
| Wolff-Parkinson-White Syndrome | 1 | 2024 | 73 | 0.210 |
Why?
|
| Tachycardia, Supraventricular | 1 | 2024 | 108 | 0.200 |
Why?
|
| Calcium | 3 | 2023 | 1031 | 0.190 |
Why?
|
| Heart Rate | 1 | 2025 | 566 | 0.190 |
Why?
|
| Gene Transfer Techniques | 2 | 2025 | 336 | 0.180 |
Why?
|
| Creatine Kinase, BB Form | 1 | 2021 | 5 | 0.180 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2021 | 1931 | 0.180 |
Why?
|
| Genetic Therapy | 1 | 2025 | 683 | 0.170 |
Why?
|
| Mice, Transgenic | 2 | 2024 | 2310 | 0.170 |
Why?
|
| Calcitonin | 1 | 2020 | 31 | 0.170 |
Why?
|
| Pedigree | 1 | 2024 | 1656 | 0.170 |
Why?
|
| Heart Failure | 3 | 2024 | 2287 | 0.170 |
Why?
|
| Paracrine Communication | 1 | 2020 | 68 | 0.160 |
Why?
|
| Myosin-Light-Chain Kinase | 1 | 2020 | 65 | 0.160 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2021 | 235 | 0.160 |
Why?
|
| Genetic Vectors | 2 | 2025 | 890 | 0.160 |
Why?
|
| Fibrinogen | 1 | 2020 | 154 | 0.160 |
Why?
|
| Regeneration | 1 | 2021 | 206 | 0.150 |
Why?
|
| Natriuretic Peptide, C-Type | 1 | 2019 | 14 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2021 | 477 | 0.150 |
Why?
|
| Disease Progression | 3 | 2024 | 2109 | 0.150 |
Why?
|
| Cell Line, Tumor | 4 | 2023 | 3497 | 0.150 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2019 | 111 | 0.140 |
Why?
|
| Gene Knock-In Techniques | 1 | 2019 | 119 | 0.140 |
Why?
|
| Protein Precursors | 1 | 2019 | 144 | 0.140 |
Why?
|
| Neuroendocrine Tumors | 1 | 2018 | 58 | 0.140 |
Why?
|
| Ankyrins | 1 | 2018 | 94 | 0.140 |
Why?
|
| Dependovirus | 1 | 2019 | 144 | 0.140 |
Why?
|
| Myocardial Infarction | 1 | 2024 | 980 | 0.130 |
Why?
|
| STAT3 Transcription Factor | 1 | 2018 | 216 | 0.130 |
Why?
|
| Carcinoma, Neuroendocrine | 1 | 2016 | 38 | 0.120 |
Why?
|
| Heterografts | 1 | 2016 | 190 | 0.120 |
Why?
|
| Tumor Burden | 1 | 2016 | 229 | 0.120 |
Why?
|
| Humans | 16 | 2025 | 126679 | 0.120 |
Why?
|
| Male | 13 | 2025 | 62490 | 0.110 |
Why?
|
| Stress, Physiological | 1 | 2016 | 257 | 0.110 |
Why?
|
| Adenocarcinoma | 2 | 2018 | 973 | 0.110 |
Why?
|
| Biomarkers, Tumor | 1 | 2021 | 1559 | 0.100 |
Why?
|
| Action Potentials | 2 | 2025 | 457 | 0.100 |
Why?
|
| Models, Biological | 1 | 2016 | 1370 | 0.090 |
Why?
|
| Mice, Inbred NOD | 2 | 2021 | 289 | 0.080 |
Why?
|
| Mice, SCID | 2 | 2021 | 568 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 3 | 2025 | 4502 | 0.070 |
Why?
|
| Neoplasms | 1 | 2023 | 2852 | 0.070 |
Why?
|
| Cells, Cultured | 2 | 2025 | 2893 | 0.070 |
Why?
|
| Phenotype | 2 | 2025 | 4302 | 0.060 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2025 | 21 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2025 | 3262 | 0.060 |
Why?
|
| Protein Interaction Maps | 1 | 2024 | 91 | 0.050 |
Why?
|
| Proteolysis | 1 | 2024 | 177 | 0.050 |
Why?
|
| Cell Differentiation | 2 | 2023 | 1842 | 0.050 |
Why?
|
| Extracellular Matrix | 1 | 2024 | 223 | 0.050 |
Why?
|
| Nitriles | 1 | 2023 | 149 | 0.050 |
Why?
|
| Membrane Glycoproteins | 1 | 2024 | 416 | 0.050 |
Why?
|
| Proteome | 1 | 2024 | 273 | 0.050 |
Why?
|
| Mice, Knockout | 2 | 2020 | 3709 | 0.050 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2023 | 225 | 0.040 |
Why?
|
| Receptors, Calcitonin | 1 | 2020 | 18 | 0.040 |
Why?
|
| Pyrazoles | 1 | 2023 | 330 | 0.040 |
Why?
|
| Collagen Type I | 1 | 2020 | 113 | 0.040 |
Why?
|
| Pyrimidines | 1 | 2023 | 405 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 1 | 2021 | 985 | 0.040 |
Why?
|
| Mutation, Missense | 1 | 2024 | 891 | 0.040 |
Why?
|
| Protein Phosphatase 1 | 1 | 2019 | 52 | 0.040 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2019 | 43 | 0.040 |
Why?
|
| Electrocardiography | 1 | 2024 | 967 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2021 | 946 | 0.040 |
Why?
|
| Luminescent Proteins | 1 | 2019 | 155 | 0.040 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 1 | 2018 | 66 | 0.040 |
Why?
|
| Genes, Reporter | 1 | 2019 | 345 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2019 | 327 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2020 | 551 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2019 | 277 | 0.030 |
Why?
|
| Female | 5 | 2024 | 68275 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2024 | 1753 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2019 | 646 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2020 | 1536 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2018 | 192 | 0.030 |
Why?
|
| Survival Rate | 1 | 2021 | 2100 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2019 | 824 | 0.030 |
Why?
|
| Prostate | 1 | 2018 | 406 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2024 | 2304 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2019 | 1204 | 0.030 |
Why?
|
| Apoptosis | 1 | 2021 | 1811 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2021 | 2397 | 0.030 |
Why?
|
| Prognosis | 1 | 2021 | 4772 | 0.020 |
Why?
|
| Mutation | 1 | 2025 | 5939 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2025 | 12537 | 0.020 |
Why?
|
| Middle Aged | 1 | 2024 | 27672 | 0.010 |
Why?
|
| Adult | 1 | 2024 | 30379 | 0.010 |
Why?
|
| Child | 1 | 2023 | 25081 | 0.010 |
Why?
|